Ruyi He
Technik-/Wissenschafts-/F&E-Leiter bei REMEGEN CO., LTD.
Vermögen: 6 Mio $ am 30.04.2024
Aktive Positionen von Ruyi He
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REMEGEN CO., LTD. | Direktor/Vorstandsmitglied | 11.05.2020 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 11.05.2020 | - | |
| SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. | Direktor/Vorstandsmitglied | 01.02.2019 | - |
| Independent Dir/Board Member | 01.02.2019 | - | |
| I-MAB | Direktor/Vorstandsmitglied | 01.06.2021 | - |
| Independent Dir/Board Member | 01.06.2021 | - | |
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 18.09.2023 | - |
| Independent Dir/Board Member | 18.09.2023 | - | |
Genuine Biotech Ltd.
 Genuine Biotech Ltd. BiotechnologyHealth Technology Genuine Biotech Ltd. engages in the development, manufacturing, and commercialization of innovative drugs for the treatment of viral, oncological, and cerebrovascular diseases. The company was founded in 2012 and is headquartered in Pingdingshan, China. | Direktor/Vorstandsmitglied | 01.08.2022 | - |
| Independent Dir/Board Member | 01.08.2022 | - |
Karriereverlauf von Ruyi He
Ehemalige bekannte Positionen von Ruyi He
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Center For Drug Evaluation of NMPA | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | - |
Ausbildung von Ruyi He
| China Medical University | Undergraduate Degree |
Statistik
International
| China | 7 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 5 |
| Independent Dir/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
| REMEGEN CO., LTD. | Health Technology |
| I-MAB | Health Technology |
| SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Center For Drug Evaluation of NMPA | |
Genuine Biotech Ltd.
Genuine Biotech Ltd. BiotechnologyHealth Technology Genuine Biotech Ltd. engages in the development, manufacturing, and commercialization of innovative drugs for the treatment of viral, oncological, and cerebrovascular diseases. The company was founded in 2012 and is headquartered in Pingdingshan, China. | Health Technology |
